What to know before driving from Surprise

What to note about the soreness

Write down the motion that brings on soreness. Reaching for a serve needs a different exam than walking downhill. Trouble rising from a chair also helps the examiner. Name the movement, not only the joint.

Note when the soreness began. Add any swelling, locking or weakness. Write down what eases the joint and what makes it worse. Bring earlier X-rays and a medicine list if you can.

Your notes work like a short checklist. They'll help you cover the important facts during the visit.

How to plan the drive to Peoria

The Peoria clinic is at 13128 N. 94th Dr., Suite 205, Peoria, AZ 85381. From Bell Road and Bullard Avenue, the off-peak estimate is about 9 miles and 15–18 minutes. In plain terms, allow more time when traffic is heavy.

Bell Road, Loop 101 and Thunderbird Road are on the usual route. Far north Surprise may mean using Loop 303 first. Ask whether you'll need someone else to drive afterward.

QC Kinetix offers orthobiologics, the medical name for blood-based shots prepared in a clinic and placed at a sore joint. Call (602) 837-PAIN if you need help finding the office.

What to bring to the visit

Bring a medicine list, old X-rays and notes from earlier care. Wear clothes that let the examiner reach the sore joint. Choose one daily task you want to improve. You might name shopping in a store or sleeping through the night.

Ask what the exam found before discussing a procedure. Then ask what you can keep doing at home. If a blood-based shot comes up, ask how it's prepared. Find out how sore the joint may feel afterward.

Before leaving, repeat the instructions in your own words. You'll catch anything that wasn't clear.

Sources

1. A meta-analysis of 11 RCTs (730 patients) with lateral epicondylitis found the timing reverses the answer: corticosteroid was significantly BETTER than PRP in the short term (under 2 months: VAS mean difference 0.93 favouring steroid; DASH 10.23 favouring steroid), the two did not differ at 2-6 months, and PRP was significantly better at 6 months or more (VAS -2.18; DASH -8.13; Mayo Elbow +16.53).

   Xu Y, et al. — Platelet-Rich Plasma Has Better Results for Long-term Functional Improvement and Pain Relief for Lateral Epicondylitis: A Systematic Review and Meta-analysis of Randomized Controlled Trials.. American Journal of Sports Medicine, 2024. DOI: 10.1177/03635465231213087.

2. A meta-analysis of 27 RCTs (1,779 patients) across rotator cuff injury, lateral epicondylitis, plantar fasciitis and tenosynovitis found no PRP advantage at one month anywhere, and in some tendons corticosteroid was better early; PRP overtook corticosteroid at 3 months for rotator cuff VAS and at 6 months for plantar fasciitis VAS and AOFAS and for tenosynovitis VAS.

   Ye Z, et al. — Platelet-rich plasma and corticosteroid injection for tendinopathy: a systematic review and meta-analysis.. BMC Musculoskeletal Disorders, 2025. DOI: 10.1186/s12891-025-08566-3.

3. A meta-analysis of 24 RCTs (1,653 participants) with plantar fasciitis found PRP produced significantly better VAS pain than corticosteroid at 3 and 6 months but not at 1 month or 12 months, and better AOFAS function scores at 3, 6 and 12 months. Plantar fascia thickness did not differ significantly at any time point.

   Zuo A, et al. — Platelet-Rich Plasma Versus Corticosteroids in the Treatment of Plantar Fasciitis: A Systematic Review and Meta-analysis.. American Journal of Physical Medicine & Rehabilitation, 2025. DOI: 10.1097/PHM.0000000000002677.

4. The AAOS third-edition clinical practice guideline on non-arthroplasty management of knee osteoarthritis contains 29 recommendations and explicitly highlights intra-articular corticosteroid, hyaluronic acid AND platelet-rich plasma as the areas where better research is still needed - including osteoarthritis characterisation, subgroup and severity stratification, control for bias, and cost-effectiveness analysis.

   Brophy RH, Fillingham YA. — AAOS Clinical Practice Guideline Summary: Management of Osteoarthritis of the Knee (Nonarthroplasty), Third Edition.. Journal of the American Academy of Orthopaedic Surgeons, 2022. DOI: 10.5435/JAAOS-D-21-01233.

5. RESTORE, the largest and most rigorously blinded placebo-controlled PRP trial in knee OA (n=288, participant-, injector- and assessor-blinded), gave three weekly injections of a commercial leukocyte-poor PRP or saline. At 12 months the change in knee pain was -2.1 vs -1.8 points (difference -0.4; 95% CI -0.9 to 0.2; P=.17) and the change in medial tibial cartilage volume was -1.4% vs -1.2% (difference -0.2%; P=.81). Twenty-nine of 31 prespecified secondary outcomes showed no between-group difference. The authors concluded the findings do not support the use of PRP for knee OA.

   Bennell KL, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.. JAMA, 2021. DOI: 10.1001/jama.2021.19415.